Clinical drug trials have been initiated across various therapeutic areas between 2018 and 2023. The number of trials and participants has been tracked, with some reports focusing on regional differences, including the rise of biotechnology in china. Details of specific trials, including those for gene therapies and cancer treatments, have also been reported.